Damora Therapeutics is trading at $20.28, up +5.24%, with healthcare-sector strength providing context; no company-specific announcement explaining the move has surfaced.
- Healthcare was up 2.12% in the supplied sector report; reporting described investors rotating from technology into healthcare.
- The latest release listed on Damora Therapeutics’ investor-relations page is an October 2 employee inducement-grant notice.
- Live trading volume was not provided, so activity level cannot be assessed.